Clinical trial
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for…
NCT00398879 · AEterna Zentaris, Industry · Completed
Key facts
| NCT number | NCT00398879 |
|---|---|
| Title | Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients |
| Official title | A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients |
| Lead sponsor | AEterna Zentaris, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colon Cancer |
| Intervention type | Drug, Other |
| Interventions | Perifosine, Capecitabine, Perifosine Placebo |
| Enrollment | 381 |
| Start date | Aug 1, 2005 |
| Primary completion | Dec 1, 2010 |
| Completion | Oct 1, 2011 |
| First posted | Nov 14, 2006 |
| Last update posted | Mar 14, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: